Nexavar enters Phase III for breast cancer
24 February 2011
Alex Shimmings
Please Login to read the full article.
24 February 2011
Alex Shimmings
alex.shimmings@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- AVEO/Astellas 2012 filing for tivozanib as it beats Nexavar in Ph III kidney cancer trial
- FDA reviewers question efficacy of Pfizer's kidney cancer drug ahead of ODAC
- NICE plans appraisal for Pfizer's Inlyta in RCC where others have failed
- EMA accepts Pfizer's axitinib for review in renal cell carcinoma
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
